148 related articles for article (PubMed ID: 36323640)
21. Long noncoding RNAs as biomarkers for the diagnosis of hepatocellular carcinoma: A meta-analysis.
Zeng C; Tang Y; Jiang Y; Zuo Z; Tao H
Pathol Res Pract; 2021 Aug; 224():153546. PubMed ID: 34332221
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis.
Zhang P; Tan X; Zhang D; Gong Q; Zhang X
PLoS One; 2021; 16(5):e0249951. PubMed ID: 33945533
[TBL] [Abstract][Full Text] [Related]
23. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
Zhang WT; Zhang GX; Zhao RZ; Gao SS
Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
[TBL] [Abstract][Full Text] [Related]
24. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
Gong X; Ning B
Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studies.
Cui Z; Chen Y; Xiao Z; Hu M; Lin Y; Chen Y; Zheng Y
Oncotarget; 2016 May; 7(18):25791-800. PubMed ID: 27015554
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
Eur Urol; 2017 Aug; 72(2):177-188. PubMed ID: 28196723
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic and prognostic significance of long noncoding RNAs expression in thyroid cancer: A systematic review and meta-analysis.
Jing W; Li X; Peng R; Lv S; Zhang Y; Cao Z; Tu J; Ming L
Pathol Res Pract; 2018 Mar; 214(3):327-334. PubMed ID: 29487006
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of PCA3 and hK2 in combination with serum PSA for prostate cancer.
Mao Z; Ji A; Yang K; He W; Hu Y; Zhang Q; Zhang D; Xie L
Medicine (Baltimore); 2018 Oct; 97(42):e12806. PubMed ID: 30334974
[TBL] [Abstract][Full Text] [Related]
29. A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Rashnoo F
Pathol Res Pract; 2022 Mar; 231():153800. PubMed ID: 35180654
[TBL] [Abstract][Full Text] [Related]
30. The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review.
Wu Z; Xu Z; Yu B; Zhang J; Yu B
Biomed Res Int; 2020; 2020():6786875. PubMed ID: 32879887
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Hao H; Chen L; Shao J
Clin Transl Oncol; 2017 Aug; 19(8):961-968. PubMed ID: 28188488
[TBL] [Abstract][Full Text] [Related]
32. Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.
Altintas DM; Allioli N; Decaussin M; de Bernard S; Ruffion A; Samarut J; Vlaeminck-Guillem V
PLoS One; 2013; 8(6):e66278. PubMed ID: 23840433
[TBL] [Abstract][Full Text] [Related]
33. lncRNA-UCA1 in the diagnosis of bladder cancer: A meta-analysis.
Ding Z; Ying W; He Y; Chen X; Jiao Y; Wang J; Zhou X
Medicine (Baltimore); 2021 Mar; 100(11):e24805. PubMed ID: 33725946
[TBL] [Abstract][Full Text] [Related]
34. Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles.
Wang J; Gao Y; Wang X; Gao Y; Li L; Zhang J; Zhang L; Che F
Int J Biol Markers; 2020 Jun; 35(2):40-48. PubMed ID: 32460591
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population.
Shen M; Chen W; Yu K; Chen Z; Zhou W; Lin X; Weng Z; Li C; Wu X; Tao Z
Exp Mol Pathol; 2011 Feb; 90(1):97-100. PubMed ID: 20970419
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Zhang G; He X; Ren C; Lin J; Wang Q
J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
[TBL] [Abstract][Full Text] [Related]
37. Abnormally Expressed lncRNAs as Potential Biomarkers for Gastric Cancer Risk: A Diagnostic Meta-Bioinformatics Analysis.
Dong YY; Zhou Q; Li H; Lv Z; Yuan Y; Sun LP
Biomed Res Int; 2022; 2022():6712625. PubMed ID: 36389111
[TBL] [Abstract][Full Text] [Related]
38. MALAT-1 Expression Correlates with Prognosis in Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis.
Ran R; Jin JW; Zhang WP
Dis Markers; 2021; 2021():5424623. PubMed ID: 34858541
[TBL] [Abstract][Full Text] [Related]
39. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
Vedder MM; de Bekker-Grob EW; Lilja HG; Vickers AJ; van Leenders GJ; Steyerberg EW; Roobol MJ
Eur Urol; 2014 Dec; 66(6):1109-15. PubMed ID: 25168616
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Performance of the Prostate Cancer Antigen 3 Test in Prostate Cancer: Systematic Review and Meta-analysis.
Lee D; Shim SR; Ahn ST; Oh MM; Moon DG; Park HS; Cheon J; Kim JW
Clin Genitourin Cancer; 2020 Oct; 18(5):402-408.e5. PubMed ID: 32280028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
